Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for reducing pain during ultrasound-guided thoracic paravertebral block puncture
ChiCTR2400082860Phase 4Recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in procedural pain, sponsored by Deyang People's Hospital. Primary endpoint: Incidence of pain at the thoracic paravertebral block puncture site at 24 hours postoperatively. Started Apr 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2400082860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082860.